Subtilase (SBT) Family:
Subtilases (e.g., SBT4.13 in Arabidopsis thaliana) are serine proteases involved in plant development and stress responses . The numbering "4.7" could imply an isoform designation, but no such isoform is documented.
Typographical Errors:
The identifier may conflate "SBT4.13" (a validated subtilase) with unrelated antibodies like "SET7" (a histone methyltransferase) .
While "SBT4.7" is unverified, SBT4.13 is a well-characterized subtilase in Arabidopsis:
Function: Regulates intracellular pH and oxidative stress responses .
Antibody Use: Studies employ polyclonal or monoclonal antibodies to detect SBT4.13 protein levels in mutant plants .
Commercial antibodies like SET7 [s4E5] (e.g., ab14820, NBP1-04298B) target the human histone methyltransferase SETD7 . These are unrelated to subtilases.
If "SBT4.7 Antibody" is a novel or proprietary reagent, the following actions are advised:
Sequence Verification: Confirm the antigen’s amino acid sequence or gene ID.
Commercial Database Search: Cross-reference with antibody vendors (e.g., Abcam, Bio-Techne).
Literature Review: Use platforms like PubMed or Google Scholar with precise search terms.
KEGG: ath:AT5G58820
STRING: 3702.AT5G58820.1
SBT4.7 antibody belongs to the family of antibodies targeting plant subtilase proteins, similar to the characterized SBT4.1 antibody that targets Arabidopsis thaliana proteins. Based on similar antibody systems, SBT4.7 likely recognizes specific epitopes of subtilase family proteins that play crucial roles in plant development and stress responses. When comparing to well-characterized antibodies like SBT4.1, researchers should note that subtilase antibodies are typically produced in rabbit hosts as polyclonal preparations, providing recognition of multiple epitopes on the target protein . Validation experiments using positive and negative controls are essential before applying this antibody to novel research questions.
Based on data from related antibodies in the subtilase family, SBT4.7 antibody would likely be effective in several key applications including ELISA, Western blot, and various immunoassay formats . For optimal results in Western blotting, researchers should follow standardized protocols including proper sample preparation, protein separation via SDS-PAGE, efficient transfer to membrane supports, blocking with 3% BSA in TBST, and overnight primary antibody incubation at 4°C . The antibody's application versatility allows researchers to investigate protein expression patterns across different developmental stages and stress conditions in plant systems, providing insights into subtilase-mediated biological processes.
Rigorous validation is critical for ensuring reliable results with SBT4.7 antibody. A comprehensive validation approach includes:
Peptide competition assays to confirm epitope specificity
Western blot analysis using positive controls (tissues known to express the target) and negative controls
Testing across multiple sample types to assess cross-reactivity
Comparison with alternative detection methods where possible
Preliminary titration experiments to determine optimal working dilutions
For plant tissue work specifically, researchers should include wild-type and knockout/knockdown samples when available to conclusively demonstrate antibody specificity. The antibody should recognize a protein of the expected molecular weight, with minimal non-specific binding that can be eliminated through optimization of washing and blocking conditions .
For Western blotting applications with SBT4.7 antibody, researchers should implement the following optimized protocol:
Extract proteins from plant tissues using ice-cold RIPA buffer supplemented with protease inhibitors
Maintain constant agitation for 30 minutes at 4°C during extraction
Centrifuge at 16,000 × g for 20 minutes at 4°C and collect the supernatant
Separate proteins via SDS-PAGE using an appropriate acrylamide percentage based on target protein size
Transfer proteins to a membrane and verify transfer quality with Ponceau S staining
Block membranes with 3% BSA in TBST for 1 hour at room temperature
Incubate with diluted SBT4.7 primary antibody overnight at 4°C
Wash thoroughly with TBST (3-5 times for 5 minutes each)
Incubate with HRP-conjugated secondary antibody for 1 hour at room temperature
Wash again with TBST and develop using chemiluminescent substrate
Image using a CCD camera-based system for optimal quantification
Following this protocol minimizes background while maximizing specific signal detection. Loading controls should be included for normalization of target protein expression levels.
When adapting SBT4.7 antibody for immunohistochemistry applications in plant tissues, researchers should consider these methodological optimizations:
Tissue fixation: Use 4% paraformaldehyde to preserve protein structure while maintaining epitope accessibility
Antigen retrieval: Implement heat-induced epitope retrieval if initial staining is weak
Blocking optimization: Test multiple blocking reagents (BSA, normal serum, commercial blockers) to identify the most effective option
Antibody dilution: Perform serial dilutions (typically 1:100 to 1:1000) to determine optimal concentration
Incubation conditions: Compare different temperatures and durations for primary antibody incubation
Detection systems: Evaluate chromogenic versus fluorescent detection methods based on research needs
Counterstaining: Select appropriate counterstains that don't interfere with target visualization
For plant tissues specifically, researchers must account for high autofluorescence by implementing appropriate quenching steps or selecting detection wavelengths that minimize interference from native fluorescent compounds.
To ensure experimental rigor when using SBT4.7 antibody, researchers must incorporate several critical controls:
Positive control: Samples known to express the target protein at detectable levels
Negative control: Samples lacking target expression (knockout lines when available)
Technical negative control: Primary antibody omission to assess non-specific binding of secondary antibody
Loading/processing control: Detection of housekeeping proteins to normalize for sample preparation variations
Peptide competition control: Pre-incubation of antibody with immunizing peptide to confirm binding specificity
Isotype control: Irrelevant antibody of the same isotype to assess non-specific binding
These controls collectively validate antibody specificity, experimental consistency, and data reliability . For quantitative analyses, researchers should additionally include standard curves with purified recombinant protein when available.
Researchers working with subtilase antibodies like SBT4.7 may encounter several technical challenges that require systematic troubleshooting:
| Problem | Possible Causes | Solutions |
|---|---|---|
| Weak or no signal | Insufficient antibody concentration, inefficient protein extraction, low target expression | Increase antibody concentration, optimize extraction protocol, extend incubation time, use signal enhancement systems |
| High background | Inadequate blocking, insufficient washing, excessive antibody concentration | Increase blocking time/concentration, implement more stringent washing, optimize antibody dilution, filter antibody solutions |
| Multiple bands | Cross-reactivity, protein degradation, post-translational modifications | Validate with peptide competition, add protease inhibitors, optimize sample preparation, use freshly prepared samples |
| Inconsistent results | Variable sample quality, antibody deterioration, protocol inconsistencies | Standardize sample preparation, aliquot antibody for single use, strictly control experimental conditions |
For plant tissue specifically, additional challenges may arise from compounds that interfere with antibody binding or detection systems. Researchers should consider using specialized extraction buffers containing polyvinylpolypyrrolidone (PVPP) to remove phenolic compounds that may affect antibody performance .
When faced with discrepancies between antibody-based detection and alternative methods, researchers should implement a methodical analysis approach:
Evaluate technical limitations of each method, recognizing that different techniques have varying sensitivities and specificities
Consider protein conformation differences that might affect epitope accessibility (native vs. denatured conditions)
Assess potential post-translational modifications that could alter antibody recognition
Investigate protein-protein interactions that might mask epitopes in certain experimental conditions
Examine experimental parameters that differ between methods (buffers, pH, temperature)
Implement additional validation experiments using orthogonal approaches
In academic publications, researchers should transparently report all contradictory findings, discuss potential explanations for differences, and clearly state the limitations of each methodology. This approach maintains scientific integrity while providing valuable insights for future investigations .
For rigorous quantitative analysis of SBT4.7 antibody-generated data, researchers should implement these methodological best practices:
Use CCD camera-based imaging systems rather than film to ensure linear signal detection across a wide dynamic range
Perform replicate experiments (minimum triplicate) with independent biological samples
Include calibration standards when possible to establish absolute quantification
Normalize target protein signals to appropriate loading controls
Use image analysis software with background subtraction capabilities
Establish signal thresholds based on negative controls
Apply appropriate statistical tests based on data distribution and experimental design
For Western blot quantification specifically, researchers should ensure the signal falls within the linear detection range of the imaging system by running preliminary experiments with different protein loading amounts . Quantitative comparisons between different proteins should be avoided unless validated with purified standards at known concentrations.
For investigating protein-protein interactions involving subtilase proteins, SBT4.7 antibody can be implemented in several advanced methodological approaches:
Co-immunoprecipitation (Co-IP): Using SBT4.7 antibody to pull down the target protein along with its binding partners
Proximity-dependent labeling: Combining antibody-based detection with BioID or APEX2 proximity labeling systems
Förster Resonance Energy Transfer (FRET): Detecting protein interactions in situ using fluorescently-labeled antibodies
In situ Proximity Ligation Assay (PLA): Visualizing protein interactions with nanometer resolution in fixed samples
ChIP-seq: Investigating protein-DNA interactions if the target subtilase functions in chromatin-associated complexes
Researchers investigating subtilase protein localization can enhance resolution and data quality by combining SBT4.7 antibody with advanced microscopy approaches:
Super-resolution microscopy (STED, STORM, PALM): Overcoming the diffraction limit to visualize protein distribution with nanometer precision
Expansion microscopy: Physically enlarging samples to improve optical resolution of standard microscopes
Light sheet microscopy: Enabling 3D visualization of protein distribution throughout thick tissue sections
Correlative Light and Electron Microscopy (CLEM): Combining immunofluorescence with ultrastructural information
Live-cell imaging: Using membrane-permeable antibody fragments to track dynamic protein movement in living cells
Each technique requires specific sample preparation and optimization for plant tissues. For example, when implementing expansion microscopy, researchers must adjust digestion protocols to account for the rigid plant cell wall while preserving antibody-epitope interactions. Quantitative co-localization analysis should be performed using specialized software with appropriate statistical validation.
For investigating subtilase involvement in plant stress responses, researchers can implement SBT4.7 antibody in several sophisticated experimental designs:
Time-course studies: Monitoring protein expression changes during stress progression using quantitative Western blotting
Tissue-specific analysis: Combining antibody-based detection with laser capture microdissection to analyze expression in specific cell types
Phosphorylation state analysis: Using phospho-specific antibodies alongside SBT4.7 to detect stress-induced post-translational modifications
Subcellular redistribution studies: Tracking protein relocalization during stress responses using immunofluorescence
Proteolytic activity assays: Correlating protein abundance (detected by SBT4.7) with enzymatic activity measurements
Comparative analysis across species: Leveraging potential cross-reactivity to examine conservation of stress responses
When designing these experiments, researchers should implement appropriate stress treatments that mimic natural conditions while allowing for controlled replication. Molecular, physiological, and phenotypic data should be integrated to establish functional relationships between subtilase activity and stress adaptation mechanisms .
The integration of SBT4.7 antibody with emerging single-cell technologies offers unprecedented insights into subtilase function at cellular resolution:
Single-cell Western blotting: Analyzing protein expression heterogeneity across individual cells within tissues
Mass cytometry (CyTOF): Combining antibody detection with metal-tagged reporters for high-dimensional single-cell analysis
Imaging mass cytometry: Preserving spatial information while achieving single-cell protein quantification
Microfluidic antibody capture: Isolating and analyzing proteins from individual cells using antibody-coated microchannels
Spatial transcriptomics combined with immunofluorescence: Correlating protein localization with gene expression patterns
These approaches allow researchers to move beyond population averages to understand cell-to-cell variability in subtilase expression and function, particularly important in heterogeneous tissues responding to localized stresses or during development .
When extending antibody applications beyond model species, researchers should implement this systematic approach:
Sequence homology analysis: Bioinformatically assess epitope conservation across species of interest
Cross-reactivity testing: Validate antibody performance in each new species through Western blotting
Extraction buffer optimization: Modify compositions to account for species-specific secondary metabolites
Fixation protocol adjustments: Optimize fixation conditions based on tissue structure and composition
Signal amplification strategies: Implement for species with low target abundance
Species-specific controls: Develop appropriate positive and negative controls for each species
This methodical approach ensures reliable detection across diverse plant lineages while accounting for species-specific challenges. Researchers should report cross-reactivity data to benefit the broader scientific community working with non-model plants .
Advanced computational methods can significantly improve the analysis of antibody-generated data:
Machine learning algorithms: Automating pattern recognition in immunofluorescence images
Network analysis: Integrating antibody-based interaction data into protein-protein interaction networks
Structural modeling: Predicting epitope locations and antibody binding properties
Systems biology integration: Combining protein expression data with transcriptomics and metabolomics
Temporal-spatial modeling: Analyzing dynamic changes in protein distribution during biological processes
Cross-study meta-analysis: Comparing antibody-based findings across multiple published datasets
These computational approaches transform descriptive antibody-based observations into mechanistic insights about protein function. Researchers should combine multiple computational methods while maintaining awareness of the assumptions and limitations inherent in each approach to ensure robust data interpretation and hypothesis generation.